Synthorx Inc.,a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, has named Dr. Laura Shawver president, director and CEO. Prior to joining Synthorx, Shawver held the following positions: CEO and director of Cleave Biosciences Inc., entrepreneur-in-residence for 5AM Ventures, CEO and director of Phenomix Corp. and president of Sugen Inc. (acquired by Pharmacia Corp). She is also a director of Relay Therapeuticsandan active member of the American Association for Cancer Research, serving on the scientific advisory committee for Stand Up to Cancer.
BTG PLC, a global specialist healthcare company, has named Gregory Barrett a non-executive director of its board of directors. Barrett is currently a non-executive director of Cutera Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
